The step would bring down the cost of coronary stents by about 380%, the Union Minister for Chemicals & Fertilizers and Parliamentary Affairs, Shri Ananthkumar said.
The ceiling prices of Bare Metal Stents (BMS), having 10% market share, has been capped at Rs. 7,260 and Drug Eluting stents (DES), having 90% market share, at Rs. 29,600.
The step is a major decisive action on the unethical margins charged at each stage in the supply chain of coronary stents.
The average MRP in the market for BMS was Rs. 45,000 and for DES Rs. 1,21,000.
This has been reduced to Rs. 7623 for BMS and Rs. 31,080 for DES.
Thus, based on price reduction, patients will get average benefit of 80-90 thousand per stent resulting into a gross relief of Rs. 4450 crores in one year.
The step is in line with Prime Minister, Shri Narendra Modi’s vision of Affordable, Quality Healthcare for All.
- (CVD) are major cause of death in India, about 25% of total deaths.
- Out of these, 90-95% CVD deaths happen due to coronary artery diseases.
- As per the report of National Commission on Macroeconomics and Health, prevalence of CAD in India is about 61.5 million as per 2015 report.
- As per Health Ministry report, more than 3.5 lakh procedures were done in 2015 which used 4.73 lakh stents.
- In 2016, the figure of cardiac stent must have been above 5 lakhs. Presently market size of India made stents is roughly 30%.
- The Minister thus stated that the new ceiling prices will promote ‘Make in India’ in a big way and seeing the huge number of patients and future requirement, foreign companies will also try to make in India for cutting costs and remain competitiv